Skip to content

Architect Total Bilirubin

by Abbott Laboratories 510(k)

Active United States

510(k) K121985

Overview

The ARCHITECT Total Bilirubin assay is a diagnostic device used for the quantitation of total bilirubin in human serum or plasma. It is designed for use on the ARCHITECT c8000 system and employs diazo colorimetry methodology to measure bilirubin, an organic compound produced during the breakdown of red blood cells, aiding in the diagnosis and treatment of conditions related to liver function and hemolysis.

The device is supplied as a reagent assay for in vitro diagnostic use and is intended for use in clinical laboratory settings. It is classified as a Class II medical device under FDA regulation number 862.1110 with product code CIG, and received FDA 510(k) clearance (K121985) on February 1, 2013, based on substantial equivalence to a legally marketed device. The assay is not described as sterile, single-use, reusable, or MRI-safe in the provided data, and no storage conditions are specified.

AI-generated from registry data, 24 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK121985 Date1 Feb 2013ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls: none on record (FDA, checked 22 Oct 2026)

Specification

510(k)

510(k) Number
FDA Product Code
CIG
Device Class
Class II
Regulation
21 CFR Part 862.1110
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Other devices from Abbott Laboratories

See all devices from Abbott Laboratories →

Questions

  • What is the ARCHITECT Total Bilirubin assay used for?

    The ARCHITECT Total Bilirubin assay is used for the quantitation of total bilirubin in human serum or plasma, aiding in the diagnosis and treatment of conditions related to liver function and hemolysis by measuring bilirubin, an organic compound produced during red blood cell breakdown.

  • How is the ARCHITECT Total Bilirubin assay supplied and what system is it designed for?

    The assay is supplied as a reagent for in vitro diagnostic use and is specifically designed for use on the ARCHITECT c8000 system, employing diazo colorimetry methodology to measure bilirubin levels in clinical laboratory settings.

  • Is the ARCHITECT Total Bilirubin assay sterile, single-use, or reusable?

    The provided data does not describe the ARCHITECT Total Bilirubin assay as sterile, single-use, or reusable; no information regarding sterility or reusability is included in the device specifications.